ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0347

Identifying Risk Factors for Fragility Fractures in Patients with Coeliac Disease: An Observational Study

Kabyar Cho1, Hamzah Amin2 and marwan Bukhari3, 1University Hospitals of Morecambe Bay NHS Foundation Trust, Barrow-In-Furness, United Kingdom, 2Lancaster University, Lancaster, United Kingdom, 3University Hospitals of Morecambe bay NHS foundation trust, Lancaster, United Kingdom

Meeting: ACR Convergence 2025

Keywords: autoimmune diseases, Bone density, Dual energy x-ray absorptiometry (DEXA), Fracture, osteoporosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 26, 2025

Title: (0337–0356) Osteoporosis & Metabolic Bone Disease – Basic & Clinical Science Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Coeliac disease (CD) is an autoimmune disease, which has been widely reported to be associated with reduced bone mineral density (BMD), leading to an increased risk of fragility fractures. The lower bone mineral density observed in coeliac disease patients may be attributed to several factors including malabsorption, vitamin D deficiency, chronic inflammation, and associations with inflammatory conditions such as osteoporosis or rheumatoid arthritis. Recent studies have found different risk factors of fragility fractures which are not currently recognised in FRAX™ tool. This observational study aims to evaluate parameters strongly associated with fracture risk in coeliac patients.

Methods: Data was collected from patients with coeliac disease who were referred for dual-energy X-ray absorptiometry (DEXA) scans in the North West of England between 2004 and 2019. Variables include patient demographics, FRAX™ risk factors, L1-L4 BMD, fat percentages of the whole body, abdomen and both femurs. Data analysis was conducted using a chi-square test for categorical variables, and student t-test for continuous variables. Subsequently, univariate and multivariate logistic regression analyses were performed to identify parameters independently associated with outcomes of fracture. Baseline characteristics included are tabulated by fracture status as shown in Table 1.

Results: A total of 1220 patients were analysed. Mean age at DEXA scan was 63.9 years (SD 14.1). 285 (23.4%) patients sustained a fracture, among which 239 (83.9%) patients were females. Patients with a fracture had a significantly lower BMD at both the femoral necks, across the entire femur, and the lumbar spine (all p< 0.001), as well as a higher fat percentage in both femurs (p< 0.001), abdomen (p=0.027), and total body fat percentage (p=0.017). Fractures were also significantly associated with steroid use (p=0.026), rheumatoid arthritis (p=0.009), and family history of fracture (p=0.047).Our univariate regression model established that a lower BMD and higher fat percentage at all measured sites were significantly associated with an increased risk of fractures. The results can be seen in Table 2. The multivariate model, adjusted for other covariates, revealed that lumbar spine BMD, abdominal fat percentage, total fat percentage, left femoral fat percentage, and positive family history were strong predictors of fracture in this group of patients. This is shown in Table 3.

Conclusion: Our study concluded that lower lumbar spine BMD is significantly associated with increased prevalence of fractures, a relationship that has not been widely recognised in larger cohort studies. In addition, abdominal fat percentage, total fat percentage, and left femoral fat percentage were found to be significant factors predisposing to increased fracture in coeliac patients. This implies the need to re-evaluate the clinical utility of fracture risk assessment tools like FRAX™ and consider incorporating additional parameters to improve fracture risk stratification in coeliac patients.

Supporting image 1Table 1. Baseline characteristics of patients with coeliac disease

Supporting image 2Table 2. Univariate regression analysis of demographics and clinical factors predicting fragility fracture in patients with coeliac disease

Supporting image 3Table 3. Significant fracture predictors in patients with coeliac disease (univariate and multivariate model)


Disclosures: K. Cho: None; H. Amin: None; m. Bukhari: None.

To cite this abstract in AMA style:

Cho K, Amin H, Bukhari m. Identifying Risk Factors for Fragility Fractures in Patients with Coeliac Disease: An Observational Study [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/identifying-risk-factors-for-fragility-fractures-in-patients-with-coeliac-disease-an-observational-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/identifying-risk-factors-for-fragility-fractures-in-patients-with-coeliac-disease-an-observational-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology